Expression of types I, III and IV collagen genes in fibrotic skin and nerve lesions of toxic oil syndrome patients
- 28 June 2008
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 93 (1) , 103-107
- https://doi.org/10.1111/j.1365-2249.1993.tb06504.x
Abstract
We have studied the skin and nerve fibrosis in toxic oil syndrome by in situ hybridization using specific cDNA probes for types I, III, and IV collagens. Fibroblasts with high levels of type I and III collagen mRNA were observed in biopsies from fibrotic skin areas. Similarly, type IV collagen mRNA was abundant in cells within the fibrotic process of the nerves. These results suggest that the excessive accumulation of collagen in toxic oil syndrome results from transcriptional activation of collagen genes in a subpopulation of fibroblasts.Keywords
This publication has 21 references indexed in Scilit:
- Interleukin‐1, Interleukin‐2, Interleukin‐4, Interleukin‐6, Tumor Necrosis Factor α, and Interferon‐γ Levels in Sera from Patients With SclerodermaArthritis & Rheumatism, 1992
- Fibrogenic cytokines: the role of immune mediators in the development of scar tissueImmunology Today, 1991
- Mitogenic effect of transforming growth factor β1 on human fibroblasts involves the induction of platelet‐derived growth factor α receptorsJournal of Cellular Physiology, 1990
- L-Tryptophan-Associated Eosinophilic Perimyositis, Neuritis, and FasciitisMedicine, 1990
- Scleroderma, Fasciitis, and Eosinophilia Associated with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- Association of the Eosinophilia–Myalgia Syndrome with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- Identification of Fibroblasts Responsible for Increased Collagen Production in Localized Scleroderma by In Situ HybridizationJournal of Investigative Dermatology, 1988
- Elevated proα2(I) collagen mRNA levels in cultured scleroderma fibroblasts result from an increased transcription rate of the corresponding geneFEBS Letters, 1987
- COLLAGEN ANTIBODIES IN TOXIC OIL DISEASEThe Lancet, 1985
- Antibodies to collagen in sclerodermaArthritis & Rheumatism, 1982